Attendees
Speakers
Exhibitors
Start-ups
Days
Registration Times
For Workshops Attendees : April 1 - Starts from 9:00 AM
For Non-Workshops Attendees : April 1 - Starts from 3:00 PM to 5:00 PM
For Main Congress Delegates and Other Attendees :
April 2 - Starts from 7:45 AM
April 3 & 4 - Starts from 8:00 AM
Registration Desk
WALTER E CONVENTION CENTER, WASHINGTON D.C. , at the entrance to Hall D on Level 2
*If possible please collect your tickets on April 1 to avoid long queues on the main congress days.
Covering Clinical Development, Bioprocessing & Manufacturing, Cancer Immunotherapy and much more
250+ leading solution providers from across the globe, featuring new ways of thinking and novel partnerships to generate solutions
Networking is at the heart of World Vaccine Congress Washington. Our congress allows you to connect directly with thousands of vaccine experts across 4 days of built-in 1-2-1 networking
Andrew Allen, M.D., Ph.D., is co-founder of Gritstone bio, and has served as President, CEO and a member of the BoD since August 2015. Prior to Gritstone bio, Dr.. Allen co-founded and was CMO at Clovis Oncology and prior to that served as CMO at Pharmion (acquired by Celgene in 2008 for $2.9B). He ...
Dr. Dan Barouch received his Ph.D. in immunology from Oxford University and his M.D. from Harvard Medical School. He is currently the William Bosworth Castle Professor of Medicine and Professor of Immunology at Harvard Medical School, Director of the Center for Virology and Vaccine Research at Beth ...
Partner, NVG LLC. Coalition manager extraordinaire, currently running the Adult Vaccine Access Coalition (AVAC) and managing the Infectious Disease Prevention Network (IDPN). Subject matter expert in vaccine policy, diabetes-related policy issues, and preventive health. Broad reach in the patient...
Dr. Crooke is the Lead Microbiologist for Vaccine Immunology in the Viral Vaccine Preventable Diseases Branch (VVPDB) at the Centers for Disease Control and Prevention. He is a member of the American Society for Virology and an investigator in the Center for Childhood Immunizations and Vaccines at...
As a medical oncologist, Kyle saw first hand the devastating effects that serious disease can have on patients and their families. This is why, after completing medical school, residency, and fellowship, he dedicated his life’s work to finding better therapies for those who desperately need them. ...
Jerome H. Kim, M.D., is the Director General of IVI and an international expert on the development and evaluation of vaccines. Prior to IVI, he served as the Principal Deputy, US Military HIV Research Program and the Chief, Laboratory of Molecular Virology and Pathogenesis at the Walter Reed Army...
Wolfgang Leitner is the chief of the Innate Immunity Section of the Basic Immunology Branch/Division of Allergy, Immunology and Transplantation (DAIT), at the National Institute of Allergy and Infectious Diseases (NIAID/NIH). He oversees the NIAID Vaccine Adjuvant Program, and his section manages...
Peter Marks, M.D., Ph.D. is the director of the Center for Biologics Evaluation and Research (CBER) at the Food and Drug Administration. The center is responsible for assuring the safety and effectiveness of biological products, including vaccines, allergenic products, blood and blood products, and ...
Dr. John Mascola is Chief Scientific Officer of ModeX Therapeutics, a company developing innovative multispecific immunotherapies for cancer and infectious disease. He is an accomplished physician-scientist, virologist and immunologist with over 25 years’ experience in research and development of...
PhD in industrial organic chemistry awarded at the University of Florence, Italy, in 2006. More than 15 years experience in the field of vaccines development, focusing her research on bacterial vaccines against AMR pathogens mainly affecting impoverished communities. Involved in the development of...
Dr. Jomana Musmar serves as the Designated Federal Officer and Executive Director of the Presidential Advisory Council on Combating Antibiotic Resistant Bacteria--a US federal advisory committee addressing all issues related to AMR through a One Health approach. Dr. Musmar also serves as a Senior...
Dr. Daniel Salmon is a Professor in Global Disease Epidemiology and Control and the Director for the Institute for Vaccine Safety at Johns Hopkins Bloomberg School of Public Health. His primary research and practice interests are in optimizing the prevention of childhood infectious diseases through ...
Graduated in Pharmacy from the University of Brasília (UnB) and in History from the State University of Londrina (UEL), Gustavo is a specialist in Public Health from the State University of Maringá (UEM), Master in Pharmacology and Toxicology from the Oswaldo Cruz Foundation (Fiocruz) and doctoral...
Dr. Alessandro Sette has devoted more than 35 years of study towards understanding the immune response, measuring immune activity, and developing disease intervention strategies against cancer, autoimmunity, allergy, and infectious diseases. The laboratory is defining in chemical terms the specific ...
Dr. Smith is the Founder, President, and Principal Investigator of VRG/NOCCR, the AMR Knoxville and New Orleans locations. He is also the CEO of Alliance for Multispecialty Research, LLC (AMR) and its 26 locations across the US. Dr. Smith has been involved as a Principal Investigator for 40 years...
Dr. E. John Wherry is currently the Chair, Department of Systems Pharmacology and Translational Therapeutics, Richard and Barbara Schiffrin President’s Distinguished Professor and Director, Institute for Immunology at the Perelman School of Medicine at the University of Pennsylvania. Dr. Wherry’s...
Dr. Newman has more than 30 years’ experience in the biotechnology sector serving in senior management roles at GeoVax (Atlanta, GA), PaxVax (San Diego, CA), Pharmexa (Horsholm, Denmark), Epimmune (San Diego, CA), Vaxcel (Atlanta, GA), Apollon (Philadelphia, PA) and Cambridge Biotech (Boston, MA)...
Sarita K. Acharya is a Principal Scientist in USP’s Global Biologics Department. Sarita’s projects at USP includes leveraging her prior experience in vaccines to identify and advance development of standards to support vaccine manufacturing. She is also involved in the development of new standards...
Dr. Colin Basler is the deputy director of CDC’s One Health Office and the CDC One Health liaison to the World Organisation for Animal Health (WOAH). He received his DVM and MPH degrees from Tufts University. Prior to joining CDC’s One Health Office, Dr. Basler trained as an Epidemic Intelligence...
Anuradha Gupta is the President of Global Immunization at the Sabin Vaccine Institute. A veteran public health leader, Ms. Gupta has in her previous roles spearheaded a host of successful global initiatives to improve the health of women and children and harness the full power of vaccines. Her work ...
Dr. Hans Keirstead is an internationally recognized stem cell expert and successful entrepreneur. Known for developing treatments for quadriplegic spinal cord injury, cancer therapies for melanoma, brain, and ovarian cancers, and a multi-pathogen vaccine, he has also advanced therapeutic research...
Dr. Ed Kelley is the Chief Global Health Officer at ApiJectHe recently left his position as the World Health Organization’s Director of Integrated Health Services, where he helped lead the organization’s COVID-19 response, creating WHO’s first public-private collaboration working directly with the...
Dr. Jules Millogo is a Public Health physician with more than 30 years of experience working in developing countries at national and international levels. He joined Merck Vaccines as Medical Director, Public Health Partnerships in August 2010. In this position he serves as Merck’s liaison with the ...
Dr. Marco Pravetoni holds the Rick L. Seaver Endowed Professorship in Brain Health, and he is a Professor of Psychiatry and Behavioral Sciences, Professor of Pharmacology, and Director of the Center for Medication Development for Substance Use Disorders and Overdose at the University of Washington...
Dr. Schmid is an author and presenter with more than 17 years’ experience in clinical trials, Phases I-IV in oncology, urologic oncology, small molecules, interferons, monoclonal antibodies, and liposomal agents. He has worked for 10 years with human blood products and PBMC isolation and 25 years...
Mia King Waldron, PhD, MSN-Ed, RN, NPD-BC Dr Waldron completed her initial nursing education in New York City, earned a MSN-Ed from University of Phoenix in 2006 and her PhD in Nursing Education from Villanova University in 2019. Dr. Waldron has worked at Children’s National Hospital in Washington ...
Michael Breen is a Scientist at Tiba Biotech. He joined Tiba after finishing his Ph.D. in Microbiology at Boston University in 2023 where he studied lung-resident B cell populations that arise after influenza virus infection. At Tiba, Michael has initiated multiple therapeutic and vaccine research...
Remaining marketing opportunities for world class solution providers are selling fast.
Contact: marc.rhys-evans@terrapinn.com